Page last updated: 2024-11-02

moxonidine and Endomyocardial Fibrosis

moxonidine has been researched along with Endomyocardial Fibrosis in 1 studies

moxonidine: structure given in first source

Endomyocardial Fibrosis: A condition characterized by the thickening of the ventricular ENDOCARDIUM and subendocardium (MYOCARDIUM), seen mostly in children and young adults in the TROPICAL CLIMATE. The fibrous tissue extends from the apex toward and often involves the HEART VALVES causing restrictive blood flow into the respective ventricles (CARDIOMYOPATHY, RESTRICTIVE).

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Törnig, J1
Amann, K1
Ritz, E1
Nichols, C1
Zeier, M1
Mall, G1

Other Studies

1 other study available for moxonidine and Endomyocardial Fibrosis

ArticleYear
Arteriolar wall thickening, capillary rarefaction and interstitial fibrosis in the heart of rats with renal failure:the effects of ramipril, nifedipine and moxonidine.
    Journal of the American Society of Nephrology : JASN, 1996, Volume: 7, Issue:5

    Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Antihypertensive Agents; Aorta, Thoracic; Arterio

1996